Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by PAR PHARM INC
FDA Drug Application 020547 by PAR PHARM INC
Application Number
020547
Application Type
New Drug Application
Sponsor Applicant
PAR PHARM INC
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
9/26/1996
N
AP
0
4/28/1997
SLR
AP
0
7/10/1997
SLR
AP
0
5/6/1998
SCM
AP
0
1/23/1998
SLR
AP
0
5/6/1998
SCM
AP
0
8/17/1998
SLR
AP
0
9/17/1999
SE1
1040
007
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20547s07ltr.pdf
9/17/1999
AP
0
9/17/1999
SE1
8337
007
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20-547-S007_Accolate.cfm
4/14/2004
AP
0
3/17/1999
SLR
8574
008
http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20547-s008_accolate.pdf
5/25/2004
AP
0
4/30/1999
SCM
AP
0
9/9/1999
SCM
AP
0
2/7/2000
SLR
8573
011
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20547-S011_Accolate.pdf
5/25/2004
AP
0
11/12/1999
SCM
AP
0
6/12/2000
SLR
AP
0
4/27/2001
SE1
6197
014
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/20547s014ltr.pdf
7/29/2003
AP
0
9/19/2000
SCM
AP
0
1/8/2001
SCM
AP
0
10/31/2003
SLR
8572
017
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20547slr017ltr.pdf
5/25/2004
AP
0
3/26/2004
SLR
8255
019
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20547slr019_accolate_lbl.pdf
4/5/2004
AP
0
6/6/2005
SLR
11775
022
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020547s022ltr.pdf
6/8/2005
AP
0
6/6/2005
SLR
11780
022
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020547s022lbl.pdf
6/8/2005
AP
0
5/29/2008
SLR
19912
025
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020547s025ltr.pdf
6/2/2008
AP
0
8/21/2009
SLR
23255
027
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020547s027lbl.pdf
8/28/2009
AP
0
8/21/2009
SLR
23986
027
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020547s027ltr.pdf
11/19/2009
AP
0
7/14/2010
SLR
25970
029
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020547s029ltr.pdf
7/15/2010
AP
0
7/14/2010
SLR
25982
029
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020547s029lbl.pdf
7/19/2010
AP
0
10/13/2010
SLR
26679
030
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020547s030ltr.pdf
10/19/2010
AP
0
10/13/2010
SLR
26703
030
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020547s030lbl.pdf
10/19/2010
AP
0
8/8/2011
SLR
29729
031
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020547s031lbl.pdf
8/8/2011
AP
0
8/8/2011
SLR
29731
031
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020547s031ltr.pdf
8/10/2011
AP
0
5/15/2013
SCM
AP
0
11/15/2013
SLR
37836
033
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020547Orig1s033ltr.pdf
11/18/2013
AP
0
11/15/2013
SLR
37894
033
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020547s033lbl.pdf
11/22/2013
AP
0
3/29/2016
SCM
Back to FDA Applications sponsored by PAR PHARM INC